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To the Editor:
We read with interest the article by
Santarpino and colleagues1 in which
they compared minimally invasive
aortic valve replacement with suture-
less valves with transcatheter aortic
valve implantation in a propensity-
matched cohort of 37 patients in
each group. They concluded that the
advantages of sutureless valves are
shorter procedural times (crossclamp
time of 38.9  13.7 minutes and car-
diopulmonary bypass time of 68.9 
20.2 minutes) and less paravalvular
leak relative to transcatheter aortic
valve implantation. They reported
a high incidence of permanent
pacemaker implantation (10.8%).
The incidence of paravalvular leak
with sutureless valves in the literature
varies from 2% to 15%.2,3 Santarpino
and colleagues attributed their low
paravalvular leak to ‘‘moderate
decalcification.’’
To produce superior results to trans-
catheter aortic valve implantation in
high-risk patients, first, zero paravalvu-
lar leak with fairly large prosthesis size
and effective orifice area and low pace-
maker implantation rate are required.
These conditions will not be met by364 The Journal of Thoracic and Cmoderate or even less decalcification
of the annulus. Second, cardiopulmo-
nary bypass is the key contraindication
to surgery for elderly patients, particu-
larly those with pulmonary dysfunc-
tion, not the duration of bypass and
clamp time. The bypass and clamp
times achieved by Santarpino and
colleagues1 with sutureless valves are
not too different from our own
propensity-matched series4 of 205 pa-
tients (crossclamp time of 49 minutes
with a range of 42-63 minutes and car-
diopulmonary bypass time of 71 mi-
nutes with a range of 59-94 minutes)
in which we used minimally invasive
incision but with valve sutures. Even
in reoperative minimal access aortic
valve replacement (with or without
concomitant procedures)with standard
suturing techniques, fairly short cross-
clamp times can be achieved.5
Very good applications of suture-
less valves would be for a patient
with a failing homograft with a
severely calcified annulus and also
for difficult reoperations when the
annulus has been destroyed.
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To the Editor:
We wish to thank Dr Soppa for his
comments on our study published in
the February issue of the Journal.1
His contribution helps to keep alive
the debate on the most appropriate
treatment strategy for high-risk
patients with severe aortic stenosis.
We acknowledge that our study had
several limitations, as was stated in
the discussion, including a lack of
randomization and failure to consider
relevant factors such as patient frailty.
The main advantage of sutureless
aortic valve replacement versus trans-
catheter aortic valve implantation is
the lower or nil rate of paravalvular
leak, which has also been confirmed
by other investigators,2 and not
a shorter cardiopulmonary bypass
time, such as suggested by Dr Soppa.
This finding is of particular relevance
given the well-recognized correlation
between even mild paravalvular
leakage and increased mortality
during follow-up.3 We congratulate
Soppa and colleagues for the results
they presented at the last Society
for Cardiothoracic Surgery Congress
showing similar aortic crossclamp
times in minimally invasive surgery
using a stented prosthesis. Recently,
we demonstrated that in patients
undergoing isolated aortic valve
replacement, the aortic crossclamp
times were reduced by 40% when a
minimally invasive approach was
